The authors reply
Crit Care Med
.
2021 May 1;49(5):e554-e555.
doi: 10.1097/CCM.0000000000004961.
Authors
Chiara Robba
1
,
Paola Rebora
2
,
Geert Meyfroidt
3
,
Giuseppe Citerio
2
4
Affiliations
1
Department of Anaesthesia and Intensive Care, Policlinico San Martino IRCCS for Oncology and Neuroscience, Genova, Italy.
2
School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
3
Department and Laboratory of Intensive Care Medicine, University Hospitals Leuven and KU Leuven, Leuven, Belgium.
4
Neurointensive Care Unit, San Gerardo Hospital, ASST-Monza, Monza, Italy.
PMID:
33854024
DOI:
10.1097/CCM.0000000000004961
No abstract available
Publication types
Letter
Comment
Associated data
ClinicalTrials.gov/NCT02210221